BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1697314)

  • 41. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
    Fulton RJ; Uhr JW; Vitetta ES
    Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.
    Yoshida M; Rybak RJ; Choi Y; Greenberg SJ; Barcos M; Kawata A; Matsuno F; Tsai H; Seon BK
    Cancer Res; 1997 Feb; 57(4):678-85. PubMed ID: 9044845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.
    Roth JA; Thomsen S; Fry KD; Scannon P; Chang C
    Cancer Res; 1989 Oct; 49(20):5708-12. PubMed ID: 2676148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of newly established monoclonal antibodies against common acute lymphoblastic leukemia antigen].
    Ishimoto K; Fujimoto J; Hata J
    Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):885-92. PubMed ID: 2462774
    [No Abstract]   [Full Text] [Related]  

  • 47. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis.
    Goldmacher VS; Scott CF; Lambert JM; McIntyre GD; Blättler WA; Collnhson AR; Stewart JK; Chong LD; Cook S; Slayter HS
    J Cell Physiol; 1989 Oct; 141(1):222-34. PubMed ID: 2528553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined immunochemotherapy of human solid tumors in nude mice.
    Weil-Hillman G; Uckun FM; Manske JM; Vallera DA
    Cancer Res; 1987 Jan; 47(2):579-85. PubMed ID: 3491678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
    Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
    Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
    Byers VS; Pawluczyk I; Berry N; Durrant L; Robins RA; Garnett MC; Price MR; Baldwin RW
    J Immunol; 1988 Jun; 140(11):4050-5. PubMed ID: 2453564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: nude mouse models.
    Hara H; Seon BK
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3390-4. PubMed ID: 3494997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biodistribution and in vivo antitumor efficacy of the systemically administered anti-human T-leukemia immunotoxins and potentiation of their efficacy by alpha-interferon.
    Yokota S; Okazaki M; Yoshida M; Seon BK
    Leuk Res; 1993 Jan; 17(1):69-79. PubMed ID: 8429682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
    Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
    Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A monoclonal antibody to common acute lymphoblastic leukemia antigen (CALLA) and its expression on several human tumor cell lines.
    Park WS; Hwang TS; Kim TJ; Park CS; Bae YM; Park SH; Lee SK
    J Korean Med Sci; 1992 Jun; 7(2):147-53. PubMed ID: 1388026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children.
    Wang LZ; Sun LR; Zhao YX; Wang LL
    Int Immunopharmacol; 2011 Sep; 11(9):1211-9. PubMed ID: 21492747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM; Manivel C; Arthur D; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Gunther R
    Blood; 1992 May; 79(9):2201-14. PubMed ID: 1373967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo antitumor activity of a panel of four monoclonal antibody-vinca alkaloid immunoconjugates which bind to three distinct epitopes of carcinoembryonic antigen.
    Starling JJ; Maciak RS; Hinson NA; Nichols CL; Briggs SL; Laguzza BC; Smith W; Corvalan JR
    Bioconjug Chem; 1992; 3(4):315-22. PubMed ID: 1382618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunoelectron microscopy studies on the modulation of common acute lymphoblastic leukemia antigen (CALLA) on NALM-6 cells: delineation of intracellular transport.
    Pulczynski S; Boesen AM; Jensen OM; Ellegaard J; Hokland P
    Leukemia; 1989 Feb; 3(2):137-44. PubMed ID: 2521368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.